Paroxysmal hemicrania responding to topiramate

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 78, Issue 1, 2007, Pages 96-97

  Cohen, A S ^a   Goadsby, P J ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; INDOMETACIN; LIDOCAINE; PROTON PUMP INHIBITOR; RANITIDINE; SUMATRIPTAN; TOPIRAMATE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPIGASTRIC PAIN; HOSPITAL DISCHARGE; HUMAN; MALE; NEUROLOGIC EXAMINATION; PAROXYSMAL HEMICRANIA; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; TREATMENT RESPONSE; WEIGHT REDUCTION; XEROSTOMIA;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; FACIAL INJURIES; FRUCTOSE; HUMANS; INDOMETHACIN; MALE; PAROXYSMAL HEMICRANIA; TREATMENT OUTCOME;

EID: 33845979091     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2006.096651     Document Type: Article

References (35)

1. Goodsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997;120:193-209.
2. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004;24(Suppl 1):1-160.
3. Antonaci F, Pareja JA, Caminero AB, et al. Chronic paroxysmal hemicrania and hemicrania continua. Parenteral indomethacin: the 'Indotest, Headache 1998;38:122-8.
4. Pareja JA, Caminero AB, Franco E, et al. Dose, efficacy and tolerability of long-term indomethacin treatment of chronic paroxysmal hemicrania and hemicrania continua. Cephalalgia 2001;21:869-78.
5. 5 Lisotto C, Maggioni F, Mainardi F, et al. Rofecoxib for the treatment of chronic paroxysmal hemicrania. Cephalalgia 2003;23:318-20.
6. Siow HC. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 2004;24:414-15.
7. Mathew NT, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000;55:316.
8. Coria F, Claveria LE, Jimenez-Jimenez FJ, et al. Episodic paroxysmal hemicrania responsive to calcium channel blockers. J Neurol Neurosurg Psychiatry 1992;55:166.
9. Matharu MS, Goadsby PJ. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology 2001;56:273-5.
10. Peres MF, Silberstein SD. Hemicrania continua responds to cyclooxygenase-2 inhibitors. Headache 2002;42:530-1.
11. Roumie CL, Arbogast PG, Mitchel EF Jr, et al. Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous. J Gen Intern Med 2005;20:879-83.
12. Silberstein SD, Neto W, Schmitt J, et al. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004;61:490-5.
13. Brandes JL, Saper JR, Diamond M, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004;291:965-73.
14. Diener HC, Tfelt-Hansen P, Dahlof C, et al. Topiramate in migraine prophylaxis-results from a placebo-controlled trial with propranolol as an active control. J Neurol 2004;251:943-50.
15. Wheeler SD, Carrazana EJ. Topiramate-treated cluster headache. Neurology 1999;53:234-6.
16. Forderreuther S, Mayer M, Straube A. Treatment of cluster headache with topiramate: effects and side-effects in five patients. Cepahalalgia 2002;22:186-9.
17. Mathew NT, Kailasam J, Meadors L. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 2002;42:796-803.
18. 18 Lainez MJ, Pascual J, Pascual AM, et al. Topiramate in the prophylactic treatment of cluster headache. Headache 2003;43:784- 9.
19. Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 2002;58:1307.
20. Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia 2004;24:985-92.
21. Rossi P, Cesarino F, Faroni J, et al. SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 2003;23:998-1000.
22. Cohen AS, Matharu MS, Goadsby PJ. Suggested guidelines for treating SUNCT and SUNA. Cephalalgia 2005;25:1200.
23. Leone M, Dodick D, Rigamonti A, et al. Topiramate in cluster headache prophylaxis: an open trial. Cephalalgia 2003;23:1001-2.
24. Black DF, Dodick DW. Two cases of medically and surgically intractable SUNCT: a reason for caution and an argument for a central mechanism. Cephalalgia 2002;22:201-4.
25. Koseoglu E, Karaman Y, Kucuk S, et al. SUNCT syndrome associated with compression of trigeminal nerve. Cephalalgia 2005;25:473-5.
26. Boes CJ, Matharu MS, Goadsby PJ. The paroxysmal hemicrania-tic syndrome. Cephalalgia 2003;23:24-8.
27. Raskin P, Donofrio PD, Rosenthal NR, et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology 2004;63:865-73.
28. Bajwa ZH, Sami N, Warfield CA, et al. Topiramate relieves refractory intercostal neuralgia. Neurology 1999;52:1917.
29. Zvartau-Hind M, Din MU, Gilani A, et al. Topiramate relieves refractory trigeminal neuralgia in MS patients. Neurology 2000;55:1587-8.
30. Gilron I, Booher SL, Rowan JS, et al. Topiramate in trigeminal neuralgia: a randomized, placebo-controlled multiple crossover pilot study. Clin Neuropharmacol 2001;24:109-12.
31. Rosenfeld WE. Topiramate: a review of the preclinical, pharmacokinetic, and clinical data. Clin Ther 1997;19:1294-308.
32. Chong MS, Libretto SE. The rationale and use of topiramate for treating neuropathic pain. Clin J Pain 2003;19:59-68.
33. Storer RJ, Goadsby PJ. Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia 2004;24:1049-56.
34. Storer RJ, Goadsby PJ. Topiramate has a locus of action outside of the trigeminocervical complex. Cephalalgia 2005;25:934.
35. Silberstein SD. Topiramate in migraine prevention. Headache 2005;45(suppl 1):S57-65.